Prevalence of immunology testing in patients treated with alglucosidase alfa with significant hypersensitivity/anaphylactic reactions (ALGMYC07390)

ENCePP Code of conduct

No

Data sources

• Data source(s), other:
  - Sanofi Genzyme Pharmacovigilance adverse event database; - Genzyme Clinical Specialty Laboratory database
• Data sources (types):
  Other

  Spontaneous reports of suspected adverse drug reactions
• Data sources (types), other:
  Routine performance of immunology testing since treatment start

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No